Nanovibronix Inc
NASDAQ:NAOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nanovibronix Inc
NASDAQ:NAOV
|
US |
|
C
|
China Sunsine Chemical Holdings Ltd
SGX:QES
|
SG |
|
Pharnext SCA
OTC:PNEXF
|
FR |
|
G
|
Gapwaves AB
STO:GAPW B
|
SE |
|
V
|
Vinyl Chemicals India Ltd
NSE:VINYLINDIA
|
IN |
|
FRONTEO Inc
TSE:2158
|
JP |
|
J
|
Jiangsu Times Textile Technology Co Ltd
SZSE:001234
|
CN |
|
Want Want China Holdings Ltd
HKEX:151
|
CN |
Nanovibronix Inc
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Elmsford, New York and currently employs 12 full-time employees. The company went IPO on 2015-04-24. The firm is focused on developing noninvasive biological response-activating devices utilizing its low intensity surface acoustic wave (SAW) technology, which targets biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products, which are in various stages of clinical and market development consist of UroShield, PainShield and WoundShield. Its PainShield family of products include PainShield MD, PainShield Plus and PainShield Relief. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. Its wholly owned subsidiary is NanoVibronix Ltd.
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Elmsford, New York and currently employs 12 full-time employees. The company went IPO on 2015-04-24. The firm is focused on developing noninvasive biological response-activating devices utilizing its low intensity surface acoustic wave (SAW) technology, which targets biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products, which are in various stages of clinical and market development consist of UroShield, PainShield and WoundShield. Its PainShield family of products include PainShield MD, PainShield Plus and PainShield Relief. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. Its wholly owned subsidiary is NanoVibronix Ltd.
